A similar decrease in CD133 and Nestin protein expression was seen when murine GL261 GBM cells were treated with 5 and 50 μM TCS, associated with an elevated protein level of GFAP (Supplemental Figure S4). The gene discussed is PROM1; the disease is glioblastoma.